Propiverine versus Tolterodine: Efficacy and Tolerability in Patients with Overactive Bladder

The study demonstrates comparable efficacy, tolerability, and improvement in the quality of life of 15 mg propiverine twice-daily and 2 mg tolterodine twice-daily in the treatment of the symptoms of idiopathic detrusor overactivity.